by Elena Iemma | Apr 21, 2025 | News
The Role of Treg Epitopes (Tregitopes) in Antibody Maturation Uncovered in New EpiVax Study: Implications for Therapeutic Antibodies PROVIDENCE, R.I., April 21, 2025 /PRNewswire/ — EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling...
by Elena Iemma | Dec 28, 2024 | Events, Featured
Tentative date: June 5 & 6, 2025 9:00am – 5:00pm (with receptions to follow!) 350 Eddy St. Providence, RI 02903 Save the Date The second Artificial Intelligence / Human Intelligence Workshop is tentatively planned for June 5 and 6th at the South Street...
by Elena Iemma | Dec 19, 2024 | Blog
Even more Fearless in 2025 2024 was a year of transformation and momentum for us—a real steppingstone to EpiVax 2.0. We are grateful to our new CEO, Rich-Henry Schabowsky, for creating a work environment where innovation moves...
by Elena Iemma | Nov 13, 2023 | Blog
This is a two-way street Hey Hey, Hallo, Hola, Ciao, Namaste, Hello, Bonjour, Konnichiwa! When do you do your “thinking” about the day? Do you do it while running? I do! And lately, I’ve been thinking about AI and Human Intelligence in vaccine development—how far...
by Elena Iemma | May 24, 2023 | Blog
AI Meets Animal Health: Smarter Vaccine Design with EpiCC™ and Human Insight The future of animal health is being shaped by powerful new technologies. At EpiVax, we’re applying AI in animal vaccine design to improve T cell epitope coverage, strengthen immune...
